EMEA/H/C/000109 ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
203	22q11.2 deletion syndrome	1

203. 22q11.2 deletion syndrome

Clinical trials : 5 / Drugs : 7 - (DrugBank : 1) / Drug target genes : 14 - Drug target pathways : 23

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-002011-61-NL (EUCTR)	13/08/2021	21/06/2021	Riluzole as treatment for psychotic and cognitive symptoms in 22q11.2 deletion syndrome	The glutamate/GABA balance as novel therapeutic target for psychotic and cognitive symptoms in 22q11 ...	22q11.2 deletion syndrome;Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]	Trade Name: Rilutek Product Name: Riluzole Product Code: EMEA/H/C/000109	Academisch ziekenhuis Maastricht	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	45	Phase 3	Netherlands

First Previous1Next Last